London Daily

Focus on the big picture.
Thursday, Oct 30, 2025

Why Hong Kong will find it tough to buy more Covid-19 jabs

Why Hong Kong will find it tough to buy more Covid-19 jabs

Countries such as Singapore and Israel have already started to administer a third jab to some citizens but Hong Kong is still conducting studies on such a move.

Hong Kong could find it difficult to secure extra doses of Covid-19 vaccines for a booster shot for residents because of its existing surplus of jabs and slow procurement procedures, experts have warned.

Medical advisers earlier this month recommended the government give a booster shot to the elderly and immunocompromised residents at some stage but without giving a specific timetable, although countries such as Singapore and Israel have already started to administer a third jab to citizens.

Some local politicians, including members of the chief executive’s de facto cabinet, obtained a third dose as part of a trial by a private hospital after their antibody levels dropped significantly, making some wonder whether ordinary residents should also get an extra shot soon.

But the head of a pharmacists’ body and public health experts interviewed by the Post said it would not be easy for Hong Kong to increase its vaccine supply even if it decided to offer residents a third dose.

“Other countries have already purchased extra doses and administered the booster, while Hong Kong is acting slowly and still waiting for local data,” Society of Hospital Pharmacists president William Chui Chun-ming said. “If we only start our negotiations with pharmaceutical firms after obtaining the results of local data, it will be too late.”

While Hong Kong is conducting several studies to assess the effectiveness and immune response of a third dose, many developed countries have already taken action, ordering extra vaccines and even administering boosters.

Israel, which had one of the fastest vaccine roll-outs in the world, in April ordered 16 million more doses from manufacturers Pfizer and Moderna for its 9.3 million population. It is also among a few countries offering booster shots to every fully vaccinated person.


Britain also secured 60 million shots in April for its booster programme, which started earlier this month. In Asia, Singapore began giving out booster shots from September 15.

No deal has been struck between the Hong Kong government and manufacturers on procuring additional supplies. The Food and Health Bureau earlier said it would keep an eye on the global situation on booster shots, and maintain close liaison with drug companies.

Seven months on from the launch of Hong Kong’s vaccination campaign in February, just 4.47 million people, or 59.5 per cent of the 7.5 million population, have received at least one shot. The elderly, prioritised for vaccine protection, have the lowest inoculation rates of all groups. Just 39.8 per cent of people in their 70s and 14.3 per cent of those aged 80 or older have received at least one shot.

The low vaccination rate has meant Hong Kong is still sitting on about 2.2 million doses of the German-manufactured BioNTech vaccine and 4.4 million Chinese-made Sinovac shots, including batches yet to be delivered to the city. The government originally procured 7.5 million doses for each brand.

Singapore has started providing a third jab to residents.


Professor Benjamin Cowling, a public health epidemiologist at the University of Hong Kong (HKU), said the city’s lacklustre vaccines uptake might hinder its bid for booster supplies especially if it ended up having to donate or sell some of its excess supplies.

But government pandemic adviser Professor Keiji Fukuda, head of HKU’s school of public health, warned of potential wastage if procurement was made too early.

“If immune protection provided by the first vaccination remains good, and if Covid-19 vaccines are changed by manufacturers in the future to keep up with evolving changes among Covid-19 viruses, then vaccine purchased too early is likely to be thrown out and wasted,” he said.

“I think the Hong Kong government does not need to hedge bets right now and order more vaccine to assure future availability.”


He and some other experts, including those from the World Health Organization, said vaccines should be distributed fairly globally while the debate on booster shots was going on.

“It is one of the terrible ironies that some countries are debating whether to administer a third dose, while others cannot get enough vaccine for the first doses,” he said.

Karen Grepin, a health economist from HKU, said that given the global shortage of vaccines at the moment and a low case count in Hong Kong, additional doses should be spent in other places rather than as boosters in the city.

“Hong Kong’s priority should be to ensure that everyone here gets fully vaccinated before we spend a lot of energy on rolling out boosters,” she said.

The uneven distribution came despite optimistic estimates on vaccine supply. According to data from Unicef, which helps with the Covax Facility, an international vaccine distribution platform co-led by the WHO, global Covid-19 vaccine production capacity was predicted to jump from 8.5 billion doses in the second half this year to 41.5 billion in 2022. The figure was likely to further rise to 42.9 billion in 2023, five times the current global population.

But Cowling said it was almost impossible to assess whether Hong Kong could secure more supply, given the scarce data on production and procurement of Covid-19 vaccines.

“All manufacturers have an interest in keeping this information private from their competitors mostly, so no one would get this market sensitive data,” he said.

Yet he said he believed capacity globally would go up. “There will definitely be more supplies next year than this year at this point in time.”

In various parts of the world new production plants are springing up, including a mainland China facility jointly run by Fosun Pharma and Germany’s BioNTech, which is expected to supply up to 1 billion doses per year. Japan is also on the path to developing home-grown coronavirus vaccines.

Newsletter

Related Articles

0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×